Aurinia Pharmaceuticals Inc (AUPH)

10:00 AM

Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD - Investing.com

10:00 AM

08:40 AM

Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance - TipRanks

08:40 AM

07:10 AM

Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

07:10 AM

07:10 AM

Aurinia: Q3 Earnings Snapshot - News-Times

07:10 AM

06:28 AM

Aurinia Pharmaceuticals Inc $AUPH Shares Bought by Hussman Strategic Advisors Inc. - MarketBeat

06:28 AM

06:19 AM

Aurinia Pharmaceuticals Q3 profit doubles on strong LUPKYNIS sales, raises FY sales view - MarketScreener

06:19 AM

06:13 AM

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

06:13 AM

06:00 AM

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Bluefield Daily Telegraph

06:00 AM

05:57 AM

Aurinia Pharmaceuticals Doubles Profit As Lupkynis Sales Jump - Finimize

05:57 AM

04:40 AM

Why Aurinia Pharmaceuticals Inc. is moving today2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com

04:40 AM

03:14 AM

Is Aurinia Pharmaceuticals Inc. stock positioned well for digital economyTrend Reversal & Safe Capital Growth Trade Ideas - newser.com

03:14 AM

03:09 AM

FDA CDER Head Janet Tidmarsh Removed Amid Aurinia Pharmaceuticals Lawsuit Alleging Misconduct - geneonline.com

03:09 AM

Nov 03, 2025

FDA Official Quits As Aurinia Sues Over 'Personal Vendetta' - Law360

Nov 03, 2025

Nov 03, 2025

FDA’s top drug regulator sued by drug company, resigns amid conduct probe - The Hill

Nov 03, 2025

Nov 03, 2025

Aurinia Pharmaceuticals Reportedly Files Lawsuit Against US FDA Official - MarketScreener

Nov 03, 2025

Nov 03, 2025

US FDA's drug division chief resigns amid ethics concerns and lawsuit - Reuters

Nov 03, 2025

Nov 03, 2025

FDA’s Top Drug Regulator Resigns, Agency Cites Personal Conduct - Bloomberg.com

Nov 03, 2025

Nov 03, 2025

Strategies to average down on Aurinia Pharmaceuticals Inc.2025 Analyst Calls & Consistent Growth Equity Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Will Aurinia Pharmaceuticals Inc. stock recover faster than marketGlobal Markets & Weekly Stock Breakout Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Aurinia Pharmaceuticals Inc expected to post earnings of 16 cents a shareEarnings Preview - TradingView

Nov 03, 2025

Nov 03, 2025

Key metrics from Aurinia Pharmaceuticals Inc.’s quarterly data2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH) - Seeking Alpha

Nov 03, 2025

Nov 03, 2025

Is Aurinia Pharmaceuticals Inc. building a consolidation baseJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025 - Business Wire

Nov 03, 2025

Nov 03, 2025

Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4 - TradingView

Nov 03, 2025

Nov 03, 2025

Can Aurinia Pharmaceuticals Inc. stock reach $100 price targetRecession Risk & Low Drawdown Investment Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

PRESS DIGEST-Wall Street JournalNovember 3 - facilitiesmanagement-now.com

Nov 03, 2025

Nov 03, 2025

Analyzing drawdowns of Aurinia Pharmaceuticals Inc. with statistical toolsWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Is Aurinia Pharmaceuticals Inc. reversing from oversold territoryMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com

Nov 03, 2025

Nov 03, 2025

Using data models to predict Aurinia Pharmaceuticals Inc. stock movementDip Buying & Free Reliable Trade Execution Plans - newser.com

Nov 03, 2025

Nov 02, 2025

Combining price and volume data for Aurinia Pharmaceuticals Inc.Weekly Trading Summary & Daily Profit Focused Stock Screening - newser.com

Nov 02, 2025

Nov 02, 2025

F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Company - The New York Times

Nov 02, 2025

Nov 02, 2025

Top FDA official Tidmarsh resigns after comments on kidney drug, HHS probe - Seeking Alpha

Nov 02, 2025

Nov 02, 2025

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits

Nov 02, 2025

Nov 02, 2025

Is Aurinia Pharmaceuticals Inc. (IKAP) stock undervalued historicallyMarket Growth Summary & Free High Return Stock Watch Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

FDA Official Steps Down, Sued by DrugmakerWSJ - The Wall Street Journal

Nov 02, 2025

Nov 02, 2025

Will breakout in Aurinia Pharmaceuticals Inc. lead to full recoveryWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 02, 2025

Nov 02, 2025

What analysts say about Aurinia Pharmaceuticals Inc IKAP stockMACD Trading Signals & Double Digit Wealth Tips - earlytimes.in

Nov 02, 2025

Nov 02, 2025

Visualizing Aurinia Pharmaceuticals Inc. stock with heatmaps2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Chart overlay techniques for tracking Aurinia Pharmaceuticals Inc.Market Performance Summary & Community Consensus Picks - newser.com

Nov 02, 2025

Nov 01, 2025

Using R and stats models for Aurinia Pharmaceuticals Inc. forecastingProfit Target & Weekly Market Pulse Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Is There An Opportunity With Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) 49% Undervaluation? - 富途牛牛

Nov 01, 2025